Clinical Trials

30 enrolled

Triple Negative Breast Neoplasms

NCT05763199 2026-03-12

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

20 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT01928589 2026-03-06

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

81 enrolled

Breast Neoplasms

NCT04928807 2026-02-27

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

231 enrolled

Rectal Neoplasms

NCT03774732 2026-02-25

NIRVANA-LUNG

327 enrolled

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03943173 2026-02-25

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

15 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05421897 2026-01-29

RAPID

Phase 1 Active not recruiting

11 enrolled

CNS

Neoplasms, Neuroblastoma

NCT03210103 2026-01-28

ORATOR2

61 enrolled

Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT05826964 2026-01-13

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

24 enrolled

Breast Neoplasms

NCT02454543 2026-01-12

g-RAMPP

452 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT03599752 2026-01-09

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

40 enrolled

Colorectal Neoplasms

NCT07306663 2025-12-29

ESO-Nanjing7

242 enrolled

Esophageal Neoplasms

NCT02153229 2025-12-26

MPM-PDT

Other solid neoplasmThoracic

52 enrolled

Epitheliod Malignant Pleural Mesothelioma

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01154920 2025-12-17

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

128 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02994069 2025-10-14

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

80 enrolled 11 charts

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT03721341 2025-09-18

SABR-COMET 10

204 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT03070366 2025-09-02

OMET

78 enrolled

Phase 1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT04046133 2025-08-05

CORINTH

52 enrolled

Anus Neoplasms

NCT06027541 2025-08-03

Young Patients With Early Breast Cancer

Active not recruiting

1,000 enrolled

Breast Cancer Female

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

798 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04528680 2025-07-31

SC9/ABX

57 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT04905316 2025-06-17

CHORUS

41 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02122185 2025-06-08

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

110 enrolled

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Pleural Effusion, Malignant

NCT06922279 2025-05-11

SOCRATE

108 enrolled

Gastroesophageal Cancer (GC)

NCT06946420 2025-04-27

SENECA

108 enrolled

Radiation Therapy

NCT00938145 2025-04-11

3 Tesla MRI in Patients With Bladder Cancer

98 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03930498 2025-01-28

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

68 enrolled

Nasopharyngeal Carcinoma

NCT04722848 2025-01-23

Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

LymphoidOther hematologic neoplasm

236 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06727357 2024-12-10

Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP

38 enrolled

Breast Neoplasms

NCT06667050 2024-10-31

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

58 enrolled

Gastric Adenocarcinoma

NCT05400070 2024-10-18

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

45 enrolled

Lung Neoplasms

NCT03018418 2024-09-19

Proton Therapy in Reducing Toxicity in Anal Cancer

14 enrolled 14 charts

Anus Neoplasms

NCT04230759 2024-09-19

RADIANCE

180 enrolled

Anus Neoplasms

NCT06518018 2024-07-24

HIBIC-NSCLC

Active not recruiting

80 enrolled

Barakat syndrome, Carcinoma, Non-Small-Cell Lung

NCT06445816 2024-06-06

Does the Level of Pain in Pediatric Oncology Patients Affect the Level of Psychological Resilience in Parents?

Active not recruiting

50 enrolled

Pain

NCT03700099 2024-04-15

Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide

Phase 1/2 Active not recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT03544736 2023-03-22

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

30 enrolled